Evaluation of a new intraoral controlled fluoride release device.

Abstract

The aim of the study was to determine the pharmacokinetics of a new hydroxyapatite-Eudragit RS100 diffusion-controlled fluoride-releasing system designed for intraoral use with a 0.15 mg F(-)/day release for a 1-month period. Matrix tablets, each containing 18 mg of sodium fluoride, were bonded to the buccal surface of the first maxillary molar teeth of 20… (More)

Topics

Cite this paper

@article{Altinova2005EvaluationOA, title={Evaluation of a new intraoral controlled fluoride release device.}, author={Y B Altinova and Alev Alaçam and A. Aydin and S. Yavuz Sanisoglu}, journal={Caries research}, year={2005}, volume={39 3}, pages={191-4} }